From humble beginnings in 1983, Sun Pharma has grown into a leading specialty generic company worldwide and the No. 1 pharmaceutical company in India. In the U.S., we are amongst the leading specialty generic companies and are ranked No. 2 in generic dermatology by prescriptions. We have a presence in 80 countries across emerging markets, with Brazil, Mexico, Russia, Romania, and South Africa being some of the key markets. We maintain a strong footprint across Western Europe, Canada, Australia, New Zealand, Israel and Japan.
Recent Posts
- Sun Pharma Announces Top-Line Results from the Phase 2 Clinical Trials Evaluating SCD-044 for Moderate to Severe Psoriasis and Atopic Dermatitis
- Press Release Completion of Checkpoint Acquisition
- Sun Pharma reports Q4 and full year results for FY25
- Sun Pharma Launches Corporate Brand Campaign in India
- Sun Pharma and Moebius Medical Announce Dual Publications on MM-II’s Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage
Recent Comments